Acrux Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.04 |
Market Cap |
$21.71 M |
Shares Outstanding |
166.5 M |
Public Float |
- |
Acrux Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.05 |
Market Cap |
AUD30.82 M |
Shares Outstanding |
166.58 M |
Public Float |
166.43 M |
Address |
103-113 Stanley Street West Melbourne Victoria (VIC) 3003 Australia |
Employees | - |
Website | http://www.acrux.com.au |
Updated | 07/08/2019 |
Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The firm develops and commercializes pharmaceutical products using unique technology to administer drugs through the skin. It operates through the following geographical segments: Australia, Switzerland, United States, and Other. |